Lung Cancer
ASCO 2021: Immunotherapy updates in lung cancer
Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune…
Date: 4th August 2021
The Lung Cancer Sessions: Highlights from BTOG 2021
VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented…
Date: 22nd June 2021
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK…
Date: 12th May 2021
The Lung Cancer Sessions: highlights from IASLC WCLC
VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights…
Date: 18th February 2021
Updates in non-small cell lung cancer from ESMO
Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung…
Date: 3rd November 2020
The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend
The European Society for Medical Oncology (ESMO) 2020 Virtual Congress brought together leading experts in oncology who updated the community…
Date: 14th October 2020
Genotyping in lung cancer and multi-cancer detection
Using precision genotyping for identifying resistance mechanisms in advanced lung cancer can help guide treatment decisions and prolong the benefit…
Date: 1st July 2020
Molecular testing for lung cancer in the UK
Molecular testing for lung cancer mutations plays an important role in the care of patients, by enabling quicker access to…
Date: 13th May 2020
